Skip to main contentAll experts

DrBen Jones

Clinical Associate Professor in Metabolic Medicine

Department of Metabolism, Digestion and Reproduction - Faculty of Medicine

Orcid identifier0000-0003-0461-2584 (opens in a new tab)⁠
  • Clinical Associate Professor in Metabolic Medicine
    Department of Metabolism, Digestion and Reproduction - Faculty of Medicine
  • Hammersmith Hospital, Hammersmith Campus, United Kingdom

RESEARCH

Research Projects
Elucidating the tissue-specific effects of biased GLP-1 receptor agonism
Development of new imaging approaches to study agonist-mediated receptor redistribution
Application of signal bias to dual GLP-1 / glucagon receptor agonism
Funding
Funding is gratefully acknowledged from the following organisations:

Medical Research Council
European Federation for the Study of Diabetes
Academy of Medical Sciences
Engineering and Physical Sciences Research Council
Society for Endocrinology
Imperial BRC

GRANTS

  • STANDARD - CALL
    Molecular mechanisms underlying divergent incretin receptor responses in ¿ versus ß cells
    Medical Research Council (MRC)1 Sep 2023 - 31 Aug 2026
    MRC: Molecular mechanisms underlying divergent incretin receptor responses in ¿ versus ß cells (2023-2026)
  • STANDARD - CALL
    Imperial BRC Metabolic & Endocrine Theme 22-27
    Imperial College Healthcare NHS Trust- BRC Funding1 Dec 2022 - 31 Mar 2028
    Imperial College Healthcare NHS Trust- BRC Funding: Imperial BRC Metabolic & Endocrine Theme 22-27 (2022-2028)
  • STANDARD - RESPONSE
    The effects of ligand, genotype and tissue diversity on GIPR trafficking responses
    Eli Lilly & Company (USA)1 Sep 2021 - 31 Aug 2023
    Eli Lilly & Company (USA): The effects of ligand, genotype and tissue diversity on GIPR trafficking responses (2021-2023)
  • GRANT
    EFSD/Boehringer Ingelheim European Research Programme on multi-system challenges in diabetes
    European Foundation for the Study of Diabetes1 Jan 2020 - 31 Mar 2022
    European Foundation for the Study of Diabetes: EFSD/Boehringer Ingelheim European Research Programme on multi-system challenges in diabetes (2020-2022)
  • GRANT
    Targeting GLP-1 receptor trafficking to improve therapies for type 2 diabetes
    Medical Research Council (MRC)16 Mar 2018 - 15 Mar 2021
    MRC: Targeting GLP-1 receptor trafficking to improve therapies for type 2 diabetes (2018-2021)
  • PROGRAMME GRANT
    Allosteric modulation of class B1 GPCRs via cholesterol binding sites
    Wellcome Trust
    Wellcome Trust: Allosteric modulation of class B1 GPCRs via cholesterol binding sites (2024-2032)
  • CLINICAL TRIAL
    Treating non-alcoholic steatohepatitis with incretin analogues
    Ureka Pharma SAS
    Ureka Pharma SAS: Treating non-alcoholic steatohepatitis with incretin analogues (2021-2023)